Wegovy acts directly on GLP-1 receptors; effects on ghrelin and leptin are indirect and vary between individuals. By strengthening...

Wegovy is a once-weekly subcutaneous injection given into the abdomen, thigh, or upper arm. Rotate sites each week and avoid areas that...

There isn’t a one-off loading dose; instead there’s a gradual dose-escalation (titration) phase. You start low and step up in stages...

Yes — both men and women can use Wegovy when they meet eligibility criteria. Because exposure in pregnancy isn’t recommended, women of...

Clinically important interactions are few, but there are practical considerations. Because Wegovy can slow stomach emptying, the...

There are no strict dietary restrictions, but simple tweaks help you feel better on treatment. Smaller portions, slower eating, and...

Wegovy was developed by Novo Nordisk as a higher-dose formulation of the GLP-1 receptor agonist semaglutide for chronic weight...

Combination weight loss medications aren’t routine in UK services because evidence for stacking treatments is limited and side-effect...

Wegovy alters appetite and satiety by activating GLP-1 receptors on neurons that signal “you’ve had enough,” while dialing down circuits...

For long-term weight loss, sustained treatment in structured services has shown meaningful average reductions, with plateaus that are...

The medicine is intended to sit alongside a reduced-calorie diet and regular movement, not replace them. People usually find it easier to...

The first few weeks focus on getting used to weekly injections and allowing your body to adapt at a low dose. Common early effects...

Appetite suppression with semaglutide comes from activating GLP-1 receptors in brain regions that govern hunger and satisfaction,...

Most people notice appetite shifts within the first few weeks, but visible results on the scale tend to appear gradually as the dose...

Some people notice appetite changes within the first few weeks, but the medicine is introduced gradually to improve tolerability, so its...

The primary target is the GLP-1 receptor, found in brain regions that regulate hunger and satiety and in the gut’s signalling pathways....

Compared with other weight-loss medications available in the UK, Wegovy relies on GLP-1 receptor activation to lower appetite, while...

Some people notice appetite changes within the first few weeks, but the medicine is introduced gradually to improve tolerability, so its...

The core benefit for weight loss is better appetite control: less urge to snack, fewer intrusive cravings, and earlier fullness at meals....

Wegovy is a once-weekly prescription medicine used within structured weight-management services for adults who meet criteria set out in...